4-(bromomethyl)-2-methoxy-1-(prop-2-yn-1-yloxy)benzene | 1299491-38-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(bromomethyl)-2-methoxy-1-(prop-2-yn-1-yloxy)benzene
• 英文别名: 4-(Bromomethyl)-2-methoxy-1-prop-2-ynoxybenzene
• CAS: 1299491-38-5
• 化学式: C₁₁H₁₁BrO₂
• 分子量: 255.111
• InChiKey: SXUYOJXPSJWHDZ-UHFFFAOYSA-N

物化性质

• 沸点：
  322.1±37.0 °C(Predicted)
• 密度：
  1.388±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  2.2
• 重原子数：
  14
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  18.5
• 氢给体数：
  0
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-羟基邻苯二甲酰亚胺 、 4-(bromomethyl)-2-methoxy-1-(prop-2-yn-1-yloxy)benzene 在 sodium hydroxide 作用下， 以 N,N-二甲基甲酰胺 为溶剂， 以79.8%的产率得到2-(3-methoxy-4-prop-2-ynyloxybenzyloxy)isoindole-1,3-dione
  参考文献：
  名称：

  Design, synthesis and antifungal activities of novel pyrrole alkaloid analogs

  摘要：

  A series of novel analogs of pyrrole alkaloid were designed and synthesized by a facile method and their structures were characterized by H-1 NMR, C-13 NMR and high-resolution mass spectrometry (HRMS). The structure of compound 2a was identified by 2D NMR including heteronuclear multiple-quantum coherence (HMQC), heteronuclear multiple-bond correlation (HMBC) and H-H correlation spectrometry (H-H COSY) spectra. Their antifungal activities against five fungi were evaluated, and the results indicated that some of the title compounds showed moderate fungicidal activities in vitro against Alternaria solani, Cercospora arachidicola, Fusarium omysporum, Gibberella zeae and Physalospora piricola at the dosage of 50 mu g mL(-1). Compound 2a and 3a exhibited good activities against P. piricola at low dosage. (C) 2011 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2011.01.031
• 作为产物：
  描述：

  4-羟基-3-甲氧基苄醇 在 四溴化碳 、 potassium carbonate 、 三苯基膦 、 potassium iodide 作用下， 以 二氯甲烷 、 丙酮 为溶剂， 反应 11.0h， 生成 4-(bromomethyl)-2-methoxy-1-(prop-2-yn-1-yloxy)benzene
  参考文献：
  名称：

  [EN] APOPTOSIS INHIBITORS
  [FR] INHIBITEURS DE L'APOPTOSE

  摘要：

  这项发明提供了一种抑制琥珀酸脱氢酶亚基B（SDHB）或共价修饰剂的化合物，以及抑制凋亡的化合物，以及这些化合物的药用盐、氢化物和立体异构体。这些化合物用于制备药物组合物，以及制备和使用方法，包括使用有效量的化合物或组合物治疗需要的人。

  公开号：

  WO2018014802A1

文献信息

• Apoptosis inhibitors
  申请人：National Institute of Biological Sciences, Beijing

  公开号：US11034680B2

  公开（公告）日：2021-06-15

  The invention provides compounds that are inhibitors or covalent modifiers of succinate dehydrogenase subunit B (SDHB) and/or inhibitors of apoptosis, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.

  本发明提供了琥珀酸脱氢酶亚基 B (SDHB) 的抑制剂或共价修饰剂和/或细胞凋亡抑制剂的化合物及其药学上可接受的盐、水合物和立体异构体。这些化合物可用于药物组合物以及制造和使用方法中，包括用有效量的化合物或组合物治疗有需要的人。
• APOPTOSIS INHIBITORS
  申请人：National Institute Of Biological Sciences, Beijing

  公开号：EP3484854B1

  公开（公告）日：2021-01-20
• Apoptosis Inhibitors
  申请人：National Institute of Biological Sciences, Beijing

  公开号：US20190152960A1

  公开（公告）日：2019-05-23

  The invention provides compounds that are inhibitors or covalent modifiers of succinate dehydrogenase subunit B (SDHB) and/or inhibitors of apoptosis, and pharmaceutically acceptable salts, hydrates and stereoisomers thereof. The compounds are employed in pharmaceutical compositions, and methods of making and use, including treating a person in need thereof with an effective amount of the compound or composition.